Tag: White House

President Barack Obama will sign an executive order today aimed at reducing the number of drug shortages; between 2005 and 2010, the number of such shortages jumped from 61 to 178. Most of the drugs reported as coming up short are generic, injected medications like cancer drugs, antibiotics, and nutritional shots for hospitalized patients. Many of the shortages are due to manufacturing delays or quality control problems, like syringes found to contain glass particles or to be contaminated with microbes. The executive order will require the Food and Drug Administration to speed review of applications for changes in manufacturing protocol or to use new or different drugs in certain circumstances.

The order also instructs the FDA to work with the Department of Justice to report possible instances of price gouging, which could lead to prosecution of companies that illegally horde certain medications or overcharge for certain drugs in times of shortage. In one instance, a company charged $990 per vial for a leukemia drug that normal fetches only $12—an 80-fold markup.